Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe for Dyslipidemia in Kidney Transplant Patients
NCT02103049Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Apr 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ezetimibe in dyslipidemia, sponsored by University Medical Centre Ljubljana. Primary endpoint: Decrease of LDL cholesterol concentration at 9 months. Started Apr 2014; status: completed.
02
Drugs
ezetimibe
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02103049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103049.